Setting priorities for HTN reviews

Cochrane Hypertension priority-setting process

We are currently undertaking an exercise to identify those of our reviews which should prioritised for publication and updating as core titles within our portfolio.  

Benefits & rationale

The priority-setting exercises are designed to confirm that we are focussing our efforts on reviews which have been cited by our stakeholders (patients, carers, clinicians, and researchers) as being of the highest importance.  

Cochrane Hypertension editorial and author teams are experiencing increasing workloads, sometimes resulting in publication delays.  Creating a portfolio of core titles will enable us to publish the highest priority titles in a more timely manner, ensuring that we are maintaining high quality and making the best use of our publically funded resources for the benefit of people making decisions about their healthcare.  

Phase 1: 

We are mapping existing Cochrane Hypertension review titles to priorities identified by the Hypertension Canada Priority Setting Partnership Group (HCPSPG), which used the James Lind Alliance priority setting process. This process is recognized by the Cochrane Priority Setting Methods Group

Phase 2:

  1. From late July until early September 2018, we will undertake a bilingual (English/Spanish) social media engagement campaign (#AskCochraneHTN) to solicit additional priorities from patients and other stakeholders via an online questionnaire.  This phase of our priority setting exercise is is inspired by our Cochrane Heart colleagues, who ran an online engagement campaign for their stakeholders in late 2016. 
  2. Respondents to the questionnaire will provide input on both their own priorities as well as those identified by the HCPSPG.
  3. Our original mappings will be revised based upon results of the engagement campaign in order to create a preliminary portfolio of priority review titles.
  4. In September 2018, the portfolio of titles will be published on this page and submitted to Cochrane's priority reviews list for their consideration.

Phase 3:

  1. Cochrane Hypertension will conduct a consultation event for patients in late October 2018, at which time we will solicit input on our initial priority titles and revise them as necessary to ensure that our priority titles align with priority topics identified in the earlier phases of our priority-setting exercise.
  2. Priority topics and titles will be revisited periodically as we continue to engage with our stakeholders